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Abstract 
 
Partial nephrectomy (PN) is currently the standard treatment for T1 renal tumors. 
Minimally invasive PN offers decreased blood loss, shorter length of stay, rapid 
convalescence, and improved cosmesis. Due to the challenges inherent in laparoscopic 
partial nephrectomy, its dissemination has been stifled. Robot-assisted partial nephrectomy 
(RAPN) offers an intuitive platform to perform minimally invasive PN. It is one of the fastest 
growing robotic procedures among all surgical subspecialties. RAPN continues to improve 
upon the oncological and functional outcomes of renal tumor extirpative therapy. Herein, 
we describe the surgical technique, outcomes, and complications of RAPN. Copyright: The 
Authors. 
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Introduction 
 
 
 
Kidney cancer incidence continues to rise 
in the United States (U.S.) (1). The rise in 
incidence is at least partially attributed to 
the increased detection of incidental 
masses with more prevalent imaging (2). In 
2015, an estimated 61,560 new cancer 
cases and 14,080 deaths will be attributed 
to kidney cancer in the U.S. (3). The 
majority of cases (> 60%) are small renal 
masses, < 4 cm (4). 
It is well established, based on 
retrospective, and prospective randomized 
trials, that renal function after partial 
nephrectomy (PN) is superior when 
compared with radical nephrectomy (RN) 
(5,6). What is still unclear is whether this 
translates to a survival benefit, as 
conflicting data abounds and is debated (7-
11). The most recent iteration of the 
American Urological Association’s 
guidelines references the advantages of PN 
and recommends it as first-line therapy for 
all T1a cancers, and T1b cancers in many 
settings (12). In accordance with this 
recommendation, PN utilization has 
increased over the past decade (13). At 
some centers, PN is employed for the 
treatment of T1a tumors nearly 90% of the 
time (14). In 2008, robot-assisted partial 
nephrectomy (RAPN) was the fastest 
growing robotic procedure among all 
surgical specialties worldwide (15). Also, 
Patel et al showed that over a time span 
corresponding to the dissemination of 
robotic technology (2000–2011), open RN 
rates decreased by 33%, PN rates increased 
by 15%, and RAPN rates increased to 14% 
at university practices and 10% at non-
university practices (16). 
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Progression of surgical treatment has 
moved from open partial nephrectomy 
(OPN), to laparoscopic partial nephrectomy 
(LPN), and most recently RAPN. LPN has 
been deemed equally effective as OPN in 
terms of long-term oncological and 
functional outcomes (17, 18). Moreover, 
LPN was found to result in reduced blood 
loss, shorter hospital stays, superior 
cosmesis, and more rapid convalescence 
when compared to OPN. The main 
deterrent that has hindered the widespread 
adoption of LPN is the technically 
demanding nature of the procedure; it is 
therefore underutilized (19). As a result, 
RAPN has been studied extensively in 
recent years with the hope of finding a 
minimally invasive nephron sparing 
approach with a learning curve more 
manageable than that of LPN. RAPN 
appears to fit this niche as the quoted 
learning curve for RAPN is approximately 
25 cases, whereas the learning curve for 
LPN is estimated to be > 200 cases (20-22). 
Urologists may also favor RAPN over LPN 
as it offers relative technical advantages 
(20) and decreased complication rates (23) 
when compared with LPN. 
Surgery 
Approach 
Gettman et al. from the Mayo Clinic 
published the first case series of RAPN in 
2004 (24). Since that time, some 
refinements in technique have 
accompanied progression of technology. 
There are various reports of technique in 
the literature which differ in minor ways 
(24-27). A brief description of some options 
is provided below. 
RAPN is performed with the da Vinci 
surgical system (Intuitive Surgical, 
Sunnyvale, CA, USA). The surgery can be 
addressed using either a transperitoneal 
approach or a retroperitoneal approach. 
Factors that dictate which approach should 
be utilized include tumor location, patient’s 
history of prior major retroperitoneal 
surgery or peritoneal surgery, dense 
perirenal inflammation/fibrosis, 
musculoskeletal limitations that preclude 
proper positioning, and surgeon preference. 
The transperitoneal approach is more 
commonly used. This is secondary to the 
fact that the retroperitoneal approach is 
more challenging due to its confined 
workspace and fewer anatomic landmarks 
(28).  However, the retroperitoneal 
approach does avoid bowel manipulation 
and allows direct exposure of the renal 
hilum (26). 
Surgeon preference also dictates the 
number of robotic arms employed; either a 
three- or four-arm configuration can be 
used (Figure 1). The use of the fourth arm 
does provide the surgeon at the console 
with more control of retraction, removing 
some delegation to the bedside assistant. 
There are multiple techniques that can be 
utilized in clamping the renal hilar vessels. 
They can be clamped individually (starting 
with the artery) using laparoscopic bulldog 
clamps or en bloc using a laparoscopic 
Satinsky clamp. The latter requires 
placement of a dedicated port. Robotic 
bulldog clamps provide the surgeon 
additional autonomy, in lieu of having to 
depute the assistant to the delicate task of 
hilar occlusion. 
Minimizing warm ischemia time 
Multiple authors have demonstrated 
potential deleterious effects of prolonged 
warm ischemia time (WIT) (29-31) although 
its significance relative to the volume of 
parenchyma preserved is debated (32). 
Although the exact threshold is unknown, 
the common goal is < 30 minutes. Several 
novel techniques have been proposed. 
First, “early-unclamping” can decrease 
WIT. In early-unclamping, the intrarenal or 
hilar blood vessels are unclamped after the 
tumor is excised and just a preliminary 
repair of the deep nephrectomy bed has 
been performed. The parenchymal 
reconstruction is performed while off clamp 
(33). Peyronnet et al. demonstrated a 
decrease in WIT across 430 patients from 
22.3 to 16.7 minutes (p < 0.0001). Blood 
loss was greater in the early unclamping 
group (369 vs. 240 mL, p = 0.001) (34). 
Next, the use of barbed suture has been 
proposed. Sammon et al. demonstrated a 
reduction in WIT from 24.7 to 18.5 minutes 
(p = 0.008) by using a V-Loc (Covidien, 
Mansfield, MA, USA) barbed suture rather 
than individually placed Vicryl sutures 
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Figure 1. A, configuration of ports for a left RAPN with use of three robotic arms; B, configuration of 
ports for a right RAPN with use of four robotic arms. 
 
(Ethicon, Cincinnati, OH, USA). Another 
evolutionary technique is referred to as 
"zero-ischemia.” A preoperative computed 
tomography 3-dimensional angiogram is 
obtained. Induced hypotension is initiated 
by the anesthesiologist. The surgeon 
identifies and controls only the tertiary or 
higher-order arterial branches that feed the 
"tumor plus margin", and thus, no 
ischemia is experienced by the renal 
remnant (35). Finally, “off clamp” 
procedures have been pursued. Tanagho et 
al. described a series of 29 clamped and 29 
off clamp RAPN. Estimated blood loss was 
higher in the off clamp group (146 mL vs. 
104 mL, p = 0.04), while mean change in 
estimated glomerular filtration rate (eGFR) 
was less (-4.9 vs. -11.7 mL/min, p = 0.03) 
(36). 
Surgical defect repair 
For renorrhaphy, either an absorbable 
monofilament or a V-Loc suture is typically 
used in a running fashion to repair large 
blood vessels and collecting system defects. 
A secondary layer may also be used to 
further approximate the deep layer of the 
resection bed. Next the renal capsule's 
outer layer is closed with large absorbable 
sutures and needles. The Washington 
University technique of “sliding-clip 
renorrhaphy,” relies upon the use of Weck 
Hem-o-Lok clips (Teleflex, Morrisville, NC, 
USA), placed on Vicryl suture, on either 
side of the defect and then slid into place 
by the surgeon, to exert tension upon the 
repair (Figure 2) (25). The Hem-o-Lok clips 
are generally reinforced with Lapra-Ty clips 
(Ethicon, Cincinnati, OH, USA) to prevent 
backsliding of the clips. This technique is 
ideally suited for RAPN, as the robotic 
instrumentation affords the surgeon the 
requisite precision in dictating the degree 
of tension placed on the repair, effectively 
eliminating the need for placement of 
surgical bolsters in the renal defect to 
achieve tight closure. While other methods 
of renorrhaphy have been suggested, the 
closing tension in sliding clip renorrhaphy 
is superior and is relatively facile to 
perform (37). 
Preoperative imaging 
Over the last several years, interest has 
grown in the development of systems to 
quantify and compare renal masses (e.g. 
PADUA, R.E.N.A.L., and C-index) (38-40). 
In 2009, Kutikov and Uzzo published their 
work on the R.E.N.A.L nephrometry score 
(RNS) (40). The components include: 
(R)adius (tumor size as diameter), 
(E)xophytic/endophytic properties, 
(N)earness to the collecting system, 
(A)nterior/posterior, and (L)ocation relative 
to the polar line. Since its inception, it was 
been well studied. RNS has been associated 
with type of surgical therapy undertaken 
(41,42) operative time (43) estimated blood 
loss (44), WIT (45), leak rate (41,46), other 
complications (43,47) and length of stay 
(48). 
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Figure 2. Sliding clip renorrhaphy. Solid lines indicate the direction of force applied to slide clips into 
position. Dashed line indicates the Hem-o-Lok clip that was placed extracorporeally on the end of the 
suture. 
 
The benefit of preoperative assessment with 
tumor quantification tools is not yet 
entirely clear in RAPN.  Some authors have 
found it to be related to percent functional 
volume preservation, nadir eGFR (49), WIT 
and collecting system entry (45). However, 
others have demonstrated either no 
predictive value (50), or no greater 
performance than a more traditional metric 
such as tumor size (51). 
 
Recent advancements 
 
The robotic ultrasound probe (Aloka, 
Tokyo, Japan) can be used once the tumor 
is exposed in order to delineate precise 
tumor borders for dissection. With the da 
Vinci Si platform, TilePro software (Intuitive 
Surgical, Sunnyvale, CA, USA) can be 
employed for visualization of the real-time 
ultrasonic images. Further, this affords the 
surgeon greater independence from bedside 
assistance and obviating the need to leave 
the console to view images (52). 
Another emerging advancement is the use 
of near-infrared fluorescence imaging. The 
component enabled in the newer da Vinci 
platforms is Firefly (Intuitive Surgical, 
Sunnyvale, CA, USA). The fluorescent 
marker often used is indocyanine green 
(ICG; Akorn, Lake Forest, IL, USA). Once a 
selected vessel branch is clamped, the ICG 
is given (5-7.5 mg), and the Firefly enacted 
at the console. Tissues receiving blood flow 
will turn fluorescent green while the 
ischemic tumor (and collateral tissue) will 
appear pale. McClintock et al. 
demonstrated increased renal function in 
the short term when compared with non-
selective arterial clamping and without the 
use of Firefly (53). 
Outcomes 
Comparison to laparoscopic partial 
nephrectomy 
Numerous studies now exist in the 
literature which favorably compare RAPN to 
LPN (54-60).  In 2015, Choi et al. 
performed a meta-analysis of 23 studies, 
comprised of 2240 patients which 
compared RAPN to LPN. The authors found 
no difference in the following perioperative 
outcomes: Clavien grade 1-2 complications 
(p = 0.62), Clavien grade 3-5 complications 
(p = 0.78), change in serum creatinine (p = 
0.65), operative time (p= 0.35), estimated 
blood loss (p=0.76), and positive surgical 
margins (p = 0.75). Patients undergoing 
RAPN had a lower rate of conversion to 
open (p = 0.02) or radical surgery (p = 
0.0006), shorter WIT (p = 0.005), smaller 
change in eGFR (p= 0.03), and shorter LOS 
(p = 0.004) (61). No randomized trial has 
been done comparing the two approaches. 
However, given the above evidence and the 
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inherent improvement of sewing with 
robotic-assistance, the robotic approach 
has garnered favor. 
“Trifecta” 
A recently introduced concept used to 
evaluate PN outcomes is the "trifecta." 
(62,63).  The three outcomes assessed are: 
negative tumor margins, functional 
preservation, and no urologic 
complications. In the original paper 
describing the “trifecta”, Hung et al. divided 
patients retrospectively into four 
chronological eras, referred to as the 
discovery era (September 1999 to 
December 2003; n = 139), the conventional 
hilar-clamping era (January 2004 to 
December 2006; n = 213), the early-
unclamping era (January 2007 to 
November 2008; n = 104) and the zero-
ischemia era (which was performed at the 
authors’ institution from March 2010 to 
October 2011; n = 78). 
Over the four eras studied, the tumors 
trended toward being larger (2.9, 2.8, 3.1 
and 3.3 cm for the discovery, conventional 
hilar-clamping, early-unclamping and zero-
ischemia eras, respectively; P = 0.08), but 
the estimated percentage of kidney 
function preserved was similar (89%, 90%, 
90%, and 88%, respectively; P = 0.3). More 
recent eras were associated with 
increasingly complex tumors, with tumors 
more likely to be >4 cm in size (P = 0.03), 
located centrally (P < 0.009) or hilar (P < 
0.0001). Nevertheless, the WITs decreased 
serially at 36, 32, 15 and 0 min, for the 
discovery, conventional hilar-clamping, 
early-unclamping and zero-ischemia eras, 
respectively (P < 0.0001). The renal 
function outcomes were superior in the 
contemporary eras, with fewer patients 
experiencing declines (P < 0.0001). The 
positive surgical margin rates were 
uniformly low (P = 0.7), and urological 
complications tended to be fewer in the 
more recent eras (P = 0.01). Trifecta 
outcomes were achieved more commonly in 
the recent eras and were 45%, 44%, 62%, 
and 68% for the discovery, conventional 
hilar-clamping, early-unclamping and zero-
ischemia eras, respectively (P = 0.0002). In 
a more recent multi-institutional study, 
Zargar et al. reported on 1185 RAPN and 
646 LPN. The authors reported a trifecta in 
70% of RAPN cases, compared to 33% of 
LPN. WIT (18 vs. 26 min), complication rate 
(16.2 vs. 25.9%), and positive surgical 
margin (PSM; 3.2 vs. 9.7%) each favored 
RAPN (54). Table 1 presents the outcomes 
of the largest series in RAPN. 
Oncological outcomes 
In the largest series reporting oncological 
outcomes to date, encompassing the work 
of five high-volume centers, Khalifeh et al. 
reviewed 943 patients who underwent 
RAPN. The PSM rate was 2.2%. Cases of 
PSM had a higher rate of recurrence and 
metastasis (p < 0.001). In fact, a PSM 
conferred an 18.4-fold higher hazard ratio 
for recurrence. Other authors have 
demonstrated similar oncologic control (55, 
58, 64-66). Furthermore, in a review of 
modern, large RAPN series, Benway and 
Bhayani found that amongst >1600 
patients, only seven recurrences (< 1%) 
were detected. The cumulative PSM rate 
was 2.7% (67). In comparison, PSM rates 
as reported by Gill et al. for LPN and OPN 
were 2.9 and 1.3%, respectively (17). 
Limited data is available regarding long-
term oncologic outcomes in RAPN given its 
relatively recent dissemination. In 2013, 
Khalifeh et al. assessed 427 patients with a 
mean tumor size of 3.0 ± 1.6 cm (68). 
Seventy patients had greater than three 
years of follow-up and 134 had at least two 
years. Overall survival was 97.0% at three 
years and 90.2% at five years. Cancer-
specific survival was 98.9% at both three 
and five year follow-up. Kyllo et al. 
demonstrated similar outcomes in a study 
of 124 patients with median follow-up of 29 
months (64). Three-year disease-free 
survival was 94.9% and cancer-specific 
survival was 99.1% based on Kaplan-Meier 
analysis. Long-term oncologic control with 
RAPN appears sound. 
Renal function 
As mentioned above, it is known that RN is 
linked to increased chronic renal 
insufficiency (9, 10, 69). PN is intended to 
mitigate the unnecessary damage to a 
patient’s renal function that RN invokes. 
The first international, multi-center study 
of 183 patients showed no significant 
postoperative change in estimated
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Table 1. Ten largest robotic partial nephrectomy series* 
Ref N 
Mean 
tumor 
size 
(cm) 
Mean 
operative 
time 
(min) 
Mean 
WIT 
(min) 
Mean 
EBL 
(mL) 
PSM 
(%) 
Complications 
(%) 
Mean 
LOS 
(days) 
Mean 
f/u 
(months) 
Mean 
Nephrometry 
94 148 2.8 197 27.8 183 4.0 6.1 1.9 18 NR 
70 183 2.9 210 23.9 132 3.8 9.8 NR 16† NR 
74 195 2.4 135† 23.8 200 1.5 NR NR 31.1 NR 
95 240 3.0† 161† 20† 100† 6.7 32.6 4† NR NR 
96 ¥ 267 2.7† 162† 17† 100† 2.4 17.6 NR 10.6† 6† 
97 § 268 2.9† 205† 18† 75† NR 22 2.8 15.4 NR 
91 347 2.8† 
112 
(console 
time) 
18† 100 3.6 14.7 NR NR 
PADUA score 
8† 
98 413 3.2 191 21 200 NA 4.3 (major) 3.6 NA NA 
99 
(non-
hilar 
vs 
hilar) 
405 
vs 
41 
2.6 vs 
3.2† 
187.4 vs 
194.5 
19.6 vs 
26.3 
208.2 
vs 
262.2 
1.5 vs 
2.4 
5.4 vs 2.4 
2.9 vs 
2.9 
NR NR 
81 886 3.0 183.6 18.8 100† NR 139(15.6) NR 13.3 6.9 
* The most recent report of each cohort is presented.  
† Median 
¥ Completely endophytic tumors excluded 
§ Includes only patients < 70 years old 
WIT = warm ischemia time, EBL = Estimated blood loss, LOS = length of stay, PSM = positive surgical margin, f/u 
= follow-up, NR = not recorded, NA = not available 
 
glomerular filtration rate (eGFR; 82.2 vs. 
79.4 mL/min/1.73 m2, p = 0.74) up to 26 
months following RAPN (70). It should be 
noted that OPN is also comparable to 
clamped RAPN in terms of percent changes 
in eGFR (71). Zargar et al. assessed 99 
patients with mercapto-acetyltriglycine 
renal scan after RAPN (72). They found the 
median (interquartile range) of total eGFR 
preservation and ipsilateral renal function 
(IRF) to be 83.8 (75.2 - 94.1%)% and 72.0 
(60.3-81.0)%, respectively.  In their cohort, 
volume of normal parenchyma removed, 
WIT > 30 minutes, body mass index, and 
the operated kidney’s preoperative eGFR 
were predictive of IRF preservation. 
Although the kidney on which was 
operated will be affected, Kumar et al. 
reported an interesting finding (73). It 
seems performing RAPN on patients with 
baseline chronic kidney disease (CKD) may 
be especially beneficial relative to other 
treatments. It has been shown that those 
with baseline CKD have a smaller 
magnitude of renal function decline 
compared to those with normal 
preoperative renal function.  
Long-term depictions of change in renal 
function are developing. In a report from 
2015, Kim et al. found that patients 
undergoing RAPN recovered more renal 
function in the long-term (60 months) than 
those who underwent LPN (74). The pattern 
of renal function recovery included a 
significant depression of renal function at 
~3-9 months, and a gradual increase after 
reaching nadir. In the RAPN group, the 
nadir was 91.2% of the baseline eGFR. The 
renal function recovered to 95.2% of the 
preoperative value at 60 months. 
Tumors greater than 4 cm 
As experience with RAPN has accumulated, 
the indications have expanded to larger 
tumors. Petros et al. retrospectively 
reviewed 445 consecutive patients from 
four centers; 85 patients had tumors > 4 
cm (stage T1b) (75). Functional outcomes 
and complications were similar to those 
with smaller tumors, and there were no 
positive margins. Other series of non-
robotic PN have demonstrated similar 
overall and cancer-specific survival for PN 
versus RN in T1b tumors (76,77). But, 
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given the 2-5% lifetime incidence of 
contralateral renal cancer (78), it is 
prudent to consider PN, and RAPN, for 
appropriate patients. 
Complications 
Early series of RAPN reported rates of 
complications as high as 20% (21). The 
complication rates in contemporary RAPN 
series, even those including large, complex 
tumors, remain similar (8.6-20.0%) (57-59). 
These overall complication rates are 
comparable to the reported complication 
rates of 13.7 and 18.6% in patients 
undergoing OPN and LPN, respectively (17). 
Furthermore, a study by Simhan et al. 
found a similar major and minor 
complication rate between RAPN and OPN 
(71). In a multi-institutional study of 450 
patients who underwent RAPN, 
complications were stratified using the 
Clavien-Dindo classification system (79, 
80). Seventy-one patients experienced a 
complication (16%), with eight 
intraoperative and 65 postoperative 
complications; 54 complications were 
classified as Clavien Grade I or II (12%), 
which required conservative management 
only, whereas 17 were Clavien Grade III or 
IV (4%) and necessitated subsequent 
intervention. This is comparable to another 
multi-institutional study of 886 
consecutive cases of RAPN performed at 
five U.S. centers which reported an overall 
complication rate of 15.6%, with 
intraoperative and postoperative 
complication rates of 2.6 and 13.0%, 
respectively. Postoperative complications 
were classified as Clavien grade I–II in 
77.0% of cases and grade III–IV in 23.0% 
(81) Updated data from this series now 
includes 1838 patients, an intraoperative 
complication rate of 2.1% and overall 
complication rate of 17.2%. The majority of 
the complications were considered Clavien 
1-2 (72.5%) (82). Of all complications, 
hemorrhagic complications occurred in 71 
(24.9%) patients, genitourinary in 72 
(25.2%), pulmonary in 38 (12.4%), 
cardiovascular in 34 (11.1%), 
gastrointestinal in 26 (8.5%), infectious in 
22 (7.2%) and other in 21 (6.9%) patients.  
Fifty-one patients (2.7%) required 
perioperative transfusion, 10 (0.05%) 
required angioembolization, and 5 (0.2%) 
required surgical exploration for 
postoperative hemorrhage.  Urine leaks 
developed in 13 (0.7%) of patients and 10 
(0.05%) patients developed postoperative 
acute renal failure. 
Hemorrhage 
Published postoperative transfusion rates 
for RAPN range from 3 to 10%, which are 
comparable to the 5.8 and 3.4% rates for 
LPN and OPN, respectively (83). 
Furthermore, the rates of postoperative 
hemorrhage after minimally invasive PN are 
relatively low (<5%) and are similar 
between laparoscopic and robotic series, 
with a rare need for angioembolization 
(0.4%) (84, 85). 
In one multi-institutional analysis of RAPN 
complications, the reported postoperative 
hemorrhage rate for RAPN was 5.8%, and 
the intraoperative hemorrhage rate was 
1.0% (hemorrhage was defined as bleeding 
requiring blood transfusion or therapeutic 
intervention) (81). Many postoperative 
hemorrhages arise from pseudoaneurysm 
or arteriovenous fistula formation which 
may result in delayed postoperative 
hemorrhage, often presenting several weeks 
after discharge (57). 
Intraoperative techniques used to decrease 
the risk of hemorrhage include the use of a 
deoxidized cellulose bolsters during 
renorrhaphy to provide compressive 
hemostasis (86); the use of a gelatin matrix 
thrombin sealant, which has been reported 
to reduce postoperative hemorrhage from 
11.8% to 3.2% (87). The use of "sliding-clip" 
renorrhaphy, and the use of barbed V-Loc 
sutures (Covidien, Mansfield, MA) during 
reconstruction, allows the even distribution 
of tension across the surgical bed to control 
transected vessels and reduce the 
likelihood of postoperative bleeding (25). 
Although not presently validated, 
checklists to prepare for and manage 
intraoperative hemorrhage are available 
(88). 
Urine leak 
Urine leak was formerly the most common 
postoperative complication of OPN with a 
rate of 17.4% (89), adding significant 
morbidity to the procedure. Minimally 
invasive approaches afford lower rates of 
urine leak when compared to open 
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approaches (41). Reported rates of urine 
leak range from 0.6 – 2.5% (90). The lowest 
reported leak rate of 0.6% comes from a 
RAPN cohort of 347 patients described by 
Ficarra et al. (91). 
Cost 
RAPN is considerably more expensive 
compared to LPN in the typical setting. 
However, in an efficient hospital and 
surgical system, the difference can be 
minimized to just $334 per case (92). 
Furthermore, as many studies suggest that 
complications are lower in RAPN compared 
to LPN, it may be reasonable to expect that 
total costs would narrow further. As health 
policy changes, penalties for readmissions 
may be assessed by the Center for 
Medicare and Medicaid Services. Such 
potential policy would make those 
operations with fewer readmissions due to 
complications more prudent (93). 
Conclusion 
PN offers improved renal function and 
similar survival to RN. RAPN facilitates the 
performance of minimally invasive PN due 
to its short learning curve. The breadth of 
cases undertaken for RAPN continues to 
expand with enduring success. Innovation 
continues to make RAPN an attractive and 
relatively facile technology with which to 
provide superb care for patients with renal 
tumors. Future research will be directed 
toward refining techniques to minimize WIT 
and to improve upon the RAPN’s 
consistency in achieving the “trifecta.” 
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